Eurofins Villapharma Research, S.L.U.

Eurofins Villapharma provides integrated chemistry solutions supporting drug discovery and preclinical development. Combining synthetic, medicinal, and analytical chemistry with in vitro ADME-Tox expertise, the company delivers decision-ready data that accelerates hit identification, lead optimization, and candidate selection. As part of the Eurofins Discovery network, Eurofins Villapharma connects chemistry, biology, and translational sciences to support the development of small molecules and advanced therapeutic modalities, including ADC payloads, peptides, targeted protein degraders (PROTACs®), and molecular glues, helping clients progress innovative therapies from concept to preclinical development.